Wellcome Trust Centre for Neuroimaging at UCL

Name :

Wellcome Trust Centre for Neuroimaging at UCL

Address  :

12 Queen Square

Town  :

London

State  :

Greater London

Country  :

UK

Post Code:

WC1N 3BG

Phone  :

+44 (0)20 3448 4362

Fax  :

+44 (0)20 7813 1420

Web URL  :



History

The Functional Imaging Laboratory FIL was founded in 1994 following a major grant award from the Wellcome Trust This provided for a new building capital equipment and core staff support

The award enabled a core group of scientists based at the Medical Research Council Cyclotron Unit at the Hammersmith Hospital to relocate their activity to a central London site within UCL

In 1994 the principal neuroimaging research tool was Positron Emission Tomography PET Over the next decade functional magnetic resonance imaging fMRI beceme the primary investigative tool of the FIL leading to PET decommissioning in 2004

Currently the investigative tools of the laboratory include functional magnetic resonance imaging fMRI magnetoencephalography MEG and electroencephalography EEG The laboratory has continued to enjoy core Wellcome Trust infrastructure support through major grant awards in 1999 and 2004

In 2006 following a successful bid for a Strategic Award the laboratory was awarded Wellcome Trust Centre status and is now known as the Wellcome Trust Centre for Neuroimaging at UCL
Quantum Installs a QRadDIGITAL DRX Series Radiographic System at St Marys Hospital in Waterbur

Long Island NY Medical equipment manufacturer Quantum Medical Imaging has completed an installation of a QRadDIGITAL DRX Series Radiographic System in the newly opened Pre Admission Testing Center at St Marys Hospital in Waterbury Connecticut The sale and installation was facilitated Parker XRay a Quantum Gold Star Dealer in the USA St Marys Hos... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More